High-Level Expression of a Recombinant Antibody from Myeloma Cells Using a Glutamine Synthetase Gene as an Amplifiable Selectable MarkerC. R. Bebbington, G. T. Yarranton, G. Renner et al.|Nature Biotechnology|1992Cited by 465
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibodySarojani Angal, John R. Adair, David J. King et al.|Molecular Immunology|1993Cited by 243
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.Oliver W. Press, Irwin D. Bernstein, Darning Shan et al.|PubMed|1996Cited by 212
Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3Dominique Desplancq, Andrew Mountain, David J. King et al.|Protein Engineering Design and Selection|1994Cited by 122
Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans.M.B. Khazaeli, Kim R. Rogers, Mansoor N. Saleh et al.|PubMed|1991Cited by 120